Operating margin improved in 4Q22 due to well controlled expenses in minor businesses. We believe the lockdown will continue to be softened. We set an upside of 31% and a price target at HK$106.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.